SCHEDULE OF RELATED PARTIES PRESENTED IN CONSOLIDATED BALANCE SHEETS (Details) - USD ($) $ in Thousands |
Dec. 31, 2024 |
Dec. 31, 2023 |
|---|---|---|
| Executive Officer [Member] | ||
| Related Party Transaction [Line Items] | ||
| Related parties payables | $ 225 | $ 150 |
| Nonexecutive Directors [Member] | ||
| Related Party Transaction [Line Items] | ||
| Related parties payables | 543 | 938 |
| Related Party [Member] | ||
| Related Party Transaction [Line Items] | ||
| Related parties payables | (2,695) | (133) |
| Related Party [Member] | Orgenesis Biotech Israel Limited [Member] | ||
| Related Party Transaction [Line Items] | ||
| Related parties payables | $ (2,695) |
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|